Skip to main content

Advertisement

Log in

Physical exercise for dermatomyositis and polymyositis: a systematic review and meta-analysis

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Trials regarding physical exercise in dermatomyositis (DM) and polymyositis (PM) are heterogeneous. We aimed to summarize and critically analyze the available evidence to support the hypothesis that exercise is safe and improves strength and aerobic capacity. We performed a systematic review of clinical trials regarding physical exercise in dermatomyositis and polymyositis, without time restriction. We included studies from MEDLINE, EMBASE, SciELO, and Web of Science, published in English, Portuguese, or Spanish, and reporting outcomes related to safety, muscle performance, or aerobic capacity. The certainty of evidence was evaluated in accordance with the GRADE methodology. Meta-analysis was carried using pooled standardized mean differences (SMD) with 95% confidence interval as effect measure. We included 19 studies and 298 patients. The certainty of evidence was downgraded due to unbalanced confounding variables. The meta-analysis demonstrated improvements in strength (SMD [95% CI] = 0.61 [0.37–0.85], P < .00001) and aerobic capacity (SMD [95% CI] = 0.82 [0.29–1.34], P = .002), with no difference in creatine phosphokinase levels (SMD [95% CI] =  − 0.23 [− 0.5–0.03], P = .08) after the interventions. No exacerbation was reported, and results were favorable in all stages of disease and ages, but might be different in the future with new classification criteria for PM and the inclusion of other idiopathic inflammatory myopathies. Novel approaches such as blood flow restriction training and aquatic plyometric exercises were promising. Physical exercise in DM/PM patients of all ages is probably safe and moderately improves muscle strength and aerobic capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The original data that support the findings of this study are available from the corresponding author [JMS], upon reasonable request.

References

  1. Dalakas MC (2015) Inflammatory muscle diseases. New Engl J Med 373:393–394

    Article  CAS  PubMed  Google Scholar 

  2. Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 8:86

    Article  Google Scholar 

  3. de Souza FHC, de Araújo DB, Vilela VS, Bezerra MC, Simões RS, Bernardo WM, Miossi R, Cunha BM, Shinjo SK (2019) Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies. Adv Rheumatol 59:6

    Article  PubMed  Google Scholar 

  4. Alexanderson H (2018) Exercise in myositis. Curr Treatm Opt Rheumatol 4:289–298

    Article  PubMed  PubMed Central  Google Scholar 

  5. Alemo Munters L, Alexanderson H, Crofford LJ, Lundberg IE (2014) New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis. Curr Rheumatol Rep 16:429

    Article  PubMed  Google Scholar 

  6. Coskun Benlidayi I, Gupta L (2021) The pathophysiological effects of exercise in the management of idiopathic inflammatory myopathies: a scoping review. Int J Rheum Dis 24:896–903

    Article  PubMed  Google Scholar 

  7. de Oliveira DS, de Souza JM, Shinjo SK (2019) Beyond medicine: physical exercise should be always considered in patients with systemic autoimmune myopathies. Autoimmun Rev 18:315–316

    Article  PubMed  Google Scholar 

  8. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A (2011) GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 64:380–382

    Article  PubMed  Google Scholar 

  9. Cochrane.org [Internet]. United Kingdom: Cochrane Collaboration [updated 2022 Mar 21; cited 2022 Mar 21]. Available from: https://methods.cochrane.org/risk-bias-2

  10. Cochrane.org [Internet]. United Kingdom: Cochrane Collaboration [updated 2022 Mar 21; cited 2022 Mar 21]. Available from: https://methods.cochrane.org/methods-cochrane/robins-i-tool

  11. Bristol.ac.uk [Internet]. Bristol: University of Bristol [updated 2022 Mar 21; cited 2022 Mar 21]. Available from: https://www.riskofbias.info/welcome/robvis-visualization-tool

  12. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW Jr, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schünemann HJ (2011) GRADE guidelines 6. Rating the quality of evidence–imprecision. J Clin Epidemiol 64:1283–1293

    Article  PubMed  Google Scholar 

  13. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, Vist G, Dahm P, Shukla VK, Higgins J, Falck-Ytter Y, Schünemann HJ, GRADE Working Group (2011) GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J Clin Epidemiol 64:1294–1302

    Article  PubMed  Google Scholar 

  14. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, Akl EA, Post PN, Norris S, Meerpohl J, Shukla VK, Nasser M, Schünemann HJ, GRADE Working Group (2011) GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol 64:1303–1310

    Article  PubMed  Google Scholar 

  15. Gradepro.org [Internet]. Hamilton: McMaster University [updated 2022 Mar 21; cited 2022 Mar 21]. Available from: https://www.gradepro.org/

  16. Cochrane.org [Internet]. United Kingdom: Cochrane Collaboration [updated 2022 Mar 21; cited 2022 Mar 21]. Available from: https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman

  17. Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, Graninger W (1998) Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 37:196–200

    Article  CAS  PubMed  Google Scholar 

  18. Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, Kerschan K, Smolen J, Graninger W (1998) Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 37:1338–1342

    Article  CAS  PubMed  Google Scholar 

  19. Alexanderson H, Stenström CH, Lundberg I (1999) Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 38:608–611

    Article  CAS  Google Scholar 

  20. Alexanderson H, Stenström CH, Jenner G, Lundberg I (2000) The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 29:295–301

    Article  CAS  PubMed  Google Scholar 

  21. Alexanderson H, Dastmalchi M, Esbjörnsson-Liljedahl M, Opava CH, Lundberg IE (2007) Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 57:768–777

    Article  PubMed  Google Scholar 

  22. Alexanderson H, Munters LA, Dastmalchi M, Loell I, Heimbürger M, Opava CH, Lundberg IE (2014) Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis – a randomized controlled single-blinded study with a 2-year followup. J Rheumatol 41:1124–1132

    Article  PubMed  Google Scholar 

  23. Varjú C, Pethö E, Kutas R, Czirják L (2003) The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil 17:83–87

    Article  PubMed  Google Scholar 

  24. Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Ståhl-Hallengren C, Richards S, Thomas EL, Hamilton G, Bell JD, Lundberg IE, Scott DL (2007) Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 57:694–702

    Article  CAS  PubMed  Google Scholar 

  25. Omori CH, Silva CA, Sallum AM, Rodrigues Pereira RM, Lúciade Sá Pinto A, Roschel H, Gualano B (2012) Exercise training in juvenile dermatomyositis. Arthritis Care Res (Hoboken) 64:1186–1194

    CAS  Google Scholar 

  26. Alemo Munters L, Dastmalchi M, Katz A, Esbjörnsson M, Loell I, Hanna B, Lidén M, Westerblad H, Lundberg IE, Alexanderson H (2013) Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther 15:R83

    Article  PubMed  PubMed Central  Google Scholar 

  27. Alemo Munters L, Dastmalchi M, Andgren V, Emilson C, Bergegård J, Regardt M, Johansson A, Orefelt Tholander I, Hanna B, Lidén M, Esbjörnsson M, Alexanderson H (2013) Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup. Arthritis Care Res (Hoboken) 65:1959–1968

    Article  Google Scholar 

  28. Riisager M, Mathiesen PR, Vissing J, Preisler N, Ørngreen MC (2013) Aerobic training in persons who have recovered from juvenile dermatomyositis. Neuromuscul Disord 23:962–968

    Article  CAS  PubMed  Google Scholar 

  29. Regardt M, Schult ML, Axelsson Y, Aldehag A, Alexanderson H, Lundberg IE, Henriksson EW (2014) Hand exercise intervention in patients with polymyositis and dermatomyositis: a pilot study. Musculoskeletal Care 12:160–172

    Article  PubMed  Google Scholar 

  30. Mattar MA, Gualano B, Perandini LA, Shinjo SK, Lima FR, Sá-Pinto AL, Roschel H (2014) Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis. Arthritis Res Ther 16:473

    Article  PubMed  PubMed Central  Google Scholar 

  31. Habers GE, Bos GJ, van Royen-Kerkhof A, Lelieveld OT, Armbrust W, Takken T, van Brussel M (2016) Muscles in motion: a randomized controlled trial on the feasibility, safety and efficacy of an exercise training programme in children and adolescents with juvenile dermatomyositis. Rheumatology (Oxford) 55:1251–1262

    Article  Google Scholar 

  32. Tiffreau V, Rannou F, Kopciuch F, Hachulla E, Mouthon L, Thoumie P, Sibilia J, Drumez E, Thevenon A (2017) Postrehabilitation functional improvements in patients with inflammatory myopathies: the results of a randomized controlled trial. Arch Phys Med Rehabil 98:227–234

    Article  PubMed  Google Scholar 

  33. de Oliveira DS, Borges IBP, de Souza JM, Gualano B, Pereira RMR, Shinjo SK (2019) Exercise training attenuates insulin resistance and improves β-cell function in patients with systemic autoimmune myopathies: a pilot study. Clin Rheumatol 38:3435–3442

    Article  PubMed  Google Scholar 

  34. Samhan A, Mohamed N, Elnaggar R, Mahmoud W (2019) Assessment of the clinical effects of aquatic-based exercises in the treatment of children with juvenile dermatomyositis: a 2x2 controlled-crossover trial. Arch Rheumatol 35:97–106

    Article  PubMed  PubMed Central  Google Scholar 

  35. Elnaggar RK, Abd El-Nabie WA (2021) Efficacy of aqua-based plyometric exercises in the rehabilitation of patients with juvenile dermatomyositis: a randomized crossover pilot study. Int J Rheum Dis 24:930–940

    Article  PubMed  Google Scholar 

  36. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

    Article  PubMed  PubMed Central  Google Scholar 

  37. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63:S118-157

    Article  Google Scholar 

  38. Josefson A, Romanus E, Carlsson J (1996) A functional index in myositis. J Rheumatol 23:1380–1384

    CAS  PubMed  Google Scholar 

  39. Deitz JC, Kartin D, Kopp K (2007) Review of the Bruininks-Oseretsky test of motor proficiency, second edition (BOT-2). Phys Occup Ther Pediatr 27:87–102.

  40. Reynolds JM, Gordon TJ, Robergs RA (2006) Prediction of one repetition maximum strength from multiple repetition maximum testing and anthropometry. J Strength Cond Res 20:584–592

    PubMed  Google Scholar 

  41. Nader GA, Lundberg IE (2009) Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol 21:599–603

    Article  CAS  PubMed  Google Scholar 

  42. Boehler JF, Hogarth MW, Barberio MD, Novak JS, Ghimbovschi S, Brown KJ, Alemo Munters L, Loell I, Chen YW, Gordish-Dressman H, Alexanderson H, Lundberg IE, Nagaraju K (2017) Effect of endurance exercise on microRNAs in myositis skeletal muscle-a randomized controlled study. PLoS ONE 12:e0183292

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Zhang H, Liu Y, Ma J, Li Z (2021) Systematic review of physical exercise for patients with idiopathic inflammatory myopathies. Nurs Health Sci 23:312–324

    Article  PubMed  Google Scholar 

  44. Alexanderson H, Boström C (2020) Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus – a systematic literature review. Best Pract Res Clin Rheumatol 34:101547

    Article  PubMed  Google Scholar 

  45. Teixeira VP, Costa TS, Moreira VCS, Campos HO (2021) Effectiveness of physical training on physical performance in patients with dermatomyositis and polymyositis: systematic review and meta-analysis. Revista de Fisioterapia e Pesquisa 28:331–342

    Article  Google Scholar 

  46. Ploeg AH, Miller MG, Holcomb WR, O’Donoghue J, Berry D, Dibbet TJ (2010) The effects of high volume aquatic plyometric training on vertical jump, muscle power, and torque. Int J Aquatic Res Educ 4:6

    Article  Google Scholar 

  47. de Souza JM, de Oliveira DS, Perin LA, Misse RG, Dos Santos AM, Gualano B, de Sá Pinto AL, Roschel H, Lima FR, Shinjo SK (2019) Feasibility, safety and efficacy of exercise training in immune-mediated necrotising myopathies: a quasi-experimental prospective study. Clin Exp Rheumatol 37:235–241

    PubMed  Google Scholar 

  48. Jensen KY, Aagaard P, Schrøder HD, Suetta C, Nielsen JL, Boyle E, Diederichsen LP (2021) High-intensity strength training in patients with idiopathic inflammatory myopathies: a randomised controlled trial protocol. BMJ Open 11:e043793

    Article  PubMed  PubMed Central  Google Scholar 

  49. de Souza FH, Behrens Pinto GL, de Souza JM, Olivo Pallo PA, Hoff LS, Shinjo SK (2020) Sporadic inclusion body myositis in the rheumatology clinic. Indian J Rheumatol 15:145–152

    Google Scholar 

  50. Ganderton C, Semciw A, Cook J, Moreira E, Pizzari T (2018) Gluteal loading versus sham exercises to improve pain and dysfunction in postmenopausal women with greater trochanteric pain syndrome: a randomized controlled trial. J Womens Health (Larchmt) 27:815–829

    Article  Google Scholar 

  51. Dalakas MC (2020) Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol 39:289–301

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism / American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955–1964

    Article  PubMed  Google Scholar 

  53. Rose MR, ENMC IBM Working Group (2013) 188th ENMC International Workshop: Inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 23:1044–1055

    Article  CAS  PubMed  Google Scholar 

  54. Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working Group (2018) 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies. Neuromuscul Disord 28:87–99

    Article  PubMed  Google Scholar 

  55. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies. Chest 138:1464–1474

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean Marcos de Souza.

Ethics declarations

Disclosures

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

da Silva, B.I.S.L., dos Santos, B.R.J., Carneiro, J.A. et al. Physical exercise for dermatomyositis and polymyositis: a systematic review and meta-analysis. Clin Rheumatol 41, 2635–2646 (2022). https://doi.org/10.1007/s10067-022-06281-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-022-06281-1

Keywords

Navigation